BackHologic Overview
Hologic, Inc.

Hologic P/E Ratio

Valuation check: HOLX's P/E ratio is 30.28, below the Healthcare sector average of 77.98.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

30.28

P/E Ratio

30.28

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Hologic (HOLX) FAQ

Hologic's p/e ratio stands at 30.28. That is below the Healthcare sector average of 77.98. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Hologic sits lower the Healthcare benchmark (77.98) with a P/E ratio of 30.28. That is roughly 61.2% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 30.28 is attractive depends on Hologic's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Hologic's P/E ratio evolved across reporting periods, while the comparison chart places HOLX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, P/E ratio is commonly used to spot outliers. Hologic's reading of 30.28 (sector avg 77.98) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.